About the Authors
- Zhihua Qiu
-
Contributed equally to this work with: Zhihua Qiu, Xiao Chen, Yanzhao Zhou, Jibin Lin
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Xiao Chen
-
Contributed equally to this work with: Zhihua Qiu, Xiao Chen, Yanzhao Zhou, Jibin Lin
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Yanzhao Zhou
-
Contributed equally to this work with: Zhihua Qiu, Xiao Chen, Yanzhao Zhou, Jibin Lin
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Jibin Lin
-
Contributed equally to this work with: Zhihua Qiu, Xiao Chen, Yanzhao Zhou, Jibin Lin
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Dan Ding
-
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Shijun Yang
-
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Fen Chen
-
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Min Wang
-
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Feng Zhu
-
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Xian Yu
-
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Zihua Zhou
-
* E-mail: liaoyh27@163.com (YL); zzhua2001@163.com (ZZ)
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
- Yuhua Liao
-
* E-mail: liaoyh27@163.com (YL); zzhua2001@163.com (ZZ)
Affiliation Laboratory of Cardiovascular Immunology, Key Laboratory of Molecular Targeted Therapies of the Ministry of Education, Institute of Cardiology, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: YHL ZHZ ZHQ XC. Performed the experiments: ZHQ XC YZZ JBL DD SJY FC MW FZ XY. Analyzed the data: YHL ZHZ ZHQ XC YZZ JBL. Contributed reagents/materials/analysis tools: ZHQ XC YZZ JBL DD SJY FC MW FZ XY. Wrote the paper: YHL ZHZ ZHQ XC.